Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Diamond

Showing results (981-990 of 1,028) with videos related to

Pageof 103
Sort By:
JAMA Oncology|December 1, 2017
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET StudyEli L Diamond, Vivek Subbiah, A Craig Lockhart, et al.
Cancer Discovery|October 18, 2014
Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disordersDavid M Hyman, Eli L Diamond, Cecile Rose T Vibat, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2026
High-throughput protein target mapping enables accelerated bioactivity discovery for ToxCast and PFAS compoundsDiwen Yang, Xiaoyun Wang, Jiabao Liu, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
High-throughput protein target mapping enables accelerated bioactivity discovery for ToxCast and PFAS compoundsDiwen Yang, Xiaoyun Wang, Jiabao Liu, et al.
Blood|August 24, 2014
Recurrent RAS and PIK3CA mutations in Erdheim-Chester diseaseJean-François Emile, Eli L Diamond, Zofia Hélias-Rodzewicz, et al.
Neuro-Oncology|August 22, 2025
Multicenter basket trial for Central Nervous System tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningiomaThomas J Kaley, Christian Grommes, Elizabeth Coffee, et al.
Blood|July 7, 2017
High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosisMatthias Papo, Eli L Diamond, Fleur Cohen-Aubart, et al.
Blood|July 25, 2023
Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patientsFrancesco Pegoraro, Martina Mazzariol, Irene Trambusti, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 10, 2023
Genome-Wide Association Study Identifies the First Germline Genetic Variant Associated With Erdheim-Chester DiseaseJavier Martínez-López, Ana Márquez, Francesco Pegoraro, et al.
The New England Journal of Medicine|August 20, 2015
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 MutationsDavid M Hyman, Igor Puzanov, Vivek Subbiah, et al.
Pageof 103

Showing results (981-990 of 1,028) with videos related to

Sort By:
Pageof 103
JAMA Oncology|December 1, 2017
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET StudyEli L Diamond, Vivek Subbiah, A Craig Lockhart, et al.
Cancer Discovery|October 18, 2014
Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disordersDavid M Hyman, Eli L Diamond, Cecile Rose T Vibat, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2026
High-throughput protein target mapping enables accelerated bioactivity discovery for ToxCast and PFAS compoundsDiwen Yang, Xiaoyun Wang, Jiabao Liu, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
High-throughput protein target mapping enables accelerated bioactivity discovery for ToxCast and PFAS compoundsDiwen Yang, Xiaoyun Wang, Jiabao Liu, et al.
Blood|August 24, 2014
Recurrent RAS and PIK3CA mutations in Erdheim-Chester diseaseJean-François Emile, Eli L Diamond, Zofia Hélias-Rodzewicz, et al.
Neuro-Oncology|August 22, 2025
Multicenter basket trial for Central Nervous System tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningiomaThomas J Kaley, Christian Grommes, Elizabeth Coffee, et al.
Blood|July 7, 2017
High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosisMatthias Papo, Eli L Diamond, Fleur Cohen-Aubart, et al.
Blood|July 25, 2023
Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patientsFrancesco Pegoraro, Martina Mazzariol, Irene Trambusti, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 10, 2023
Genome-Wide Association Study Identifies the First Germline Genetic Variant Associated With Erdheim-Chester DiseaseJavier Martínez-López, Ana Márquez, Francesco Pegoraro, et al.
The New England Journal of Medicine|August 20, 2015
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 MutationsDavid M Hyman, Igor Puzanov, Vivek Subbiah, et al.
Pageof 103